Regulus Therapeutics (RGLS) Institutional Ownership → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free RGLS Stock Alerts $2.33 +0.11 (+4.95%) (As of 08:32 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Regulus Therapeutics (NASDAQ:RGLS)CurrentInstitutional OwnershipPercentage92.38%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$15.51MNumber ofInstitutional Sellers(last 12 months)0 Get RGLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Regulus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RGLS Institutional Buying and Selling by Quarter Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Regulus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/22/2024 Vivo Capital LLC5,000,000$14.40M1.1%N/A7.638% 2/5/2024Victory Capital Management Inc.271,736$348K0.0%+16.5%1.344% 11/13/2023FMR LLC2,922,600$4.03M0.0%+32.4%14.454% 11/6/2023Victory Capital Management Inc.233,207$322K0.0%+5.3%1.197% 8/14/2023Prelude Capital Management LLC40,660$60K0.0%N/A0.209% 9/16/2022Federated Hermes Inc.2,904,826$6.01M0.0%-90.0%19.850% Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/16/2022DAFNA Capital Management LLC555,555$1.15M0.3%-90.0%3.797% 8/12/2022Ikarian Capital LLC105,341$217K0.0%-91.8%0.722% 8/1/2022Victory Capital Management Inc.221,506$459K0.0%-90.1%1.517% 7/19/2022Commonwealth Equity Services LLC22,000$45K0.0%-83.2%0.151% 2/14/2022DAFNA Capital Management LLC5,555,555$1.75M0.4%N/A6.382% 1/19/2022Asymmetry Capital Management L.P.2,731,044$860K0.5%+94.9%3.137% 11/15/2021GSA Capital Partners LLP64,708$45K0.0%-68.6%0.074% 11/4/2021Asymmetry Capital Management L.P.1,401,491$968K0.6%-3.4%1.610% 10/29/2021Commonwealth Equity Services LLC111,000$76K0.0%+38.8%0.128% 9/17/2021Virtu Financial LLC79,193$64K0.0%N/A0.091% 8/27/2021Endurant Capital Management LP2,607,674$2.12M0.6%+9.7%2.996% 8/16/2021State Street Corp176,494$144K0.0%N/A0.203% 8/13/2021Geode Capital Management LLC589,196$479K0.0%+54.3%0.786% 8/13/2021Vanguard Group Inc.3,095,237$2.52M0.0%-3.9%4.131% 8/12/2021Lido Advisors LLC57,500$47K0.0%N/A0.077% 8/11/2021Commonwealth Equity Services LLC80,000$65K0.0%+300.0%0.107% 8/10/2021Strategic Wealth Advisors Group LLC74,800$61K0.0%N/A0.100% 8/5/2021GSA Capital Partners LLP206,265$168K0.0%N/A0.275% 7/31/2021Asymmetry Capital Management L.P.1,450,777$1.18M0.8%-26.9%1.936% 7/15/2021Focused Wealth Management Inc200,000$163K0.0%+100.0%0.267% 5/19/2021Squarepoint Ops LLC159,804$249K0.0%+1,477.7%0.213% 5/17/2021Endurant Capital Management LP2,376,557$3.71M1.0%N/A3.172% 5/17/2021Ikarian Capital LLC1,245,989$1.94M0.1%N/A1.663% 5/17/2021Atom Investors LP337,228$526K0.1%N/A0.450% 5/17/2021Goldman Sachs Group Inc.18,049$28K0.0%-68.0%0.024% 5/12/2021Northern Trust Corp117,654$184K0.0%+198.4%0.157% 5/12/2021Geode Capital Management LLC381,892$595K0.0%+493.5%0.510% 5/11/2021Acadian Asset Management LLC465,678$726K0.0%N/A0.622% 5/11/2021Asymmetry Capital Management L.P.1,985,472$3.10M1.6%N/A2.650% 5/4/2021Commonwealth Equity Services LLC20,000$31K0.0%N/A0.027% 5/4/2021Victory Capital Management Inc.2,227,199$3.47M0.0%+345.4%2.976% 5/3/2021Focused Wealth Management Inc100,000$156K0.0%N/A0.134% 2/10/2021Renaissance Technologies LLC449,200$606K0.0%N/A1.147% 2/5/2021BlackRock Inc.49,788$68K0.0%-23.2%0.127% top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…2/2/2021 Grimes & Company Inc.54,511$74K0.0%+127.1%0.139% 2/2/2021GYL Financial Synergies LLC51,376$69K0.0%N/A0.131% 2/1/2021Victory Capital Management Inc.499,989$675K0.0%N/A1.277% 10/20/2020Wedbush Securities Inc.70,204$36K0.0%+241.2%0.193% 8/14/2020BVF Inc. IL1,450,000$988K0.1%-9.0%6.892% 8/7/2020Virtu Financial LLC84,348$57K0.0%N/A0.401% 5/12/2020Rockefeller Capital Management L.P.84,642$39K0.0%-22.9%0.402% (Data available from 1/1/2016 forward) RGLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RGLS shares? During the previous two years, the following institutional investors and hedge funds held shares of Regulus Therapeutics shares: Vivo Capital LLC ($14.40M), Federated Hermes Inc. ($6.01M), FMR LLC ($4.03M), DAFNA Capital Management LLC ($1.15M), Victory Capital Management Inc. ($348K), Ikarian Capital LLC ($217K), and Prelude Capital Management LLC ($60K).Learn more on RGLS's institutional investors. What percentage of Regulus Therapeutics stock is owned by institutional investors? 92.38% of Regulus Therapeutics stock is owned by institutional investors. Learn more on RGLS's institutional investor holdings. Which institutional investors have been buying Regulus Therapeutics stock? The following institutional investors have purchased Regulus Therapeutics stock in the last 24 months: Vivo Capital LLC ($5M), FMR LLC ($716K), Victory Capital Management Inc. ($50.23K), and Prelude Capital Management LLC ($40.66K). How much institutional buying is happening at Regulus Therapeutics? Institutional investors have bought a total of 5,806,890 shares in the last 24 months. This purchase volume represents approximately $15.51M in transactions. Which Regulus Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Regulus Therapeutics stock in the last 24 months: Federated Hermes Inc. ($26.14M), DAFNA Capital Management LLC ($5M), Victory Capital Management Inc. ($2.01M), Ikarian Capital LLC ($1.18M), and Commonwealth Equity Services LLC ($109K). How much institutional selling is happening at Regulus Therapeutics? Institutional investors have sold a total of 34,447,753 shares in the last 24 months. This volume of shares sold represents approximately $71.31M in transactions. Related Companies: Rigel Pharmaceuticals Major Shareholders Emergent BioSolutions Major Shareholders Vanda Pharmaceuticals Major Shareholders Verastem Major Shareholders XOMA Major Shareholders Bolt Biotherapeutics Major Shareholders Lexicon Pharmaceuticals Major Shareholders scPharmaceuticals Major Shareholders Renovaro Major Shareholders Inventiva Major Shareholders This page (NASDAQ:RGLS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
